Scilex Holding Co. (SCLX)
5.45
-0.04
(-0.82%)
USD |
NASDAQ |
Sep 01, 15:48
Scilex EPS Diluted (Quarterly) : -16.65 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.65 |
| March 31, 2026 | -6.279 |
| December 31, 2025 | -4.708 |
| September 30, 2025 | -22.17 |
| June 30, 2025 | -7.422 |
| March 31, 2025 | -2.255 |
| December 31, 2024 | -1.234 |
| September 30, 2024 | -1.210 |
| June 30, 2024 | -10.94 |
| March 31, 2024 | -8.331 |
| December 31, 2023 | -7.489 |
| September 30, 2023 | -8.894 |
| Date | Value |
|---|---|
| June 30, 2023 | -6.540 |
| March 31, 2023 | -7.598 |
| December 31, 2022 | -7.468 |
| September 30, 2022 | 5.646 |
| June 30, 2022 | -4.692 |
| March 31, 2022 | -2.406 |
| December 31, 2021 | 0.2985 |
| September 30, 2021 | -2.930 |
| June 30, 2021 | -0.4742 |
| March 31, 2021 | 2.696 |
| December 31, 2020 | -0.0007 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.839 |
| Semnur Pharmaceuticals, Inc. | -0.0189 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -116.22M |
| Revenue (Quarterly) | 7.642M |
| Total Expenses (Quarterly) | 122.37M |
| Enterprise Value | 141.89M |
| Gross Profit Margin (Quarterly) | 14.73% |
| Profit Margin (Quarterly) | -1.52K% |
| Earnings Yield | -913.8% |
| Normalized Earnings Yield | -612.46 |